- Home
- CIA vs SLP Comparison
CIA vs SLP Comparison
Compare CIA & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIA
- SLP
- Stock Information
- Founded
- CIA 1969
- SLP 1996
- Country
- CIA United States
- SLP United States
- Employees
- CIA N/A
- SLP N/A
- Industry
- CIA Life Insurance
- SLP EDP Services
- Sector
- CIA Finance
- SLP Technology
- Exchange
- CIA Nasdaq
- SLP Nasdaq
- Market Cap
- CIA 261.8M
- SLP 282.4M
- IPO Year
- CIA N/A
- SLP 1997
- Fundamental
- Price
- CIA $5.22
- SLP $13.84
- Analyst Decision
- CIA
- SLP Buy
- Analyst Count
- CIA 0
- SLP 7
- Target Price
- CIA N/A
- SLP $29.50
- AVG Volume (30 Days)
- CIA 143.9K
- SLP 360.6K
- Earning Date
- CIA 11-06-2025
- SLP 10-22-2025
- Dividend Yield
- CIA N/A
- SLP N/A
- EPS Growth
- CIA N/A
- SLP N/A
- EPS
- CIA 0.22
- SLP N/A
- Revenue
- CIA $245,943,000.00
- SLP $80,383,000.00
- Revenue This Year
- CIA $4.22
- SLP $12.75
- Revenue Next Year
- CIA $4.46
- SLP $3.06
- P/E Ratio
- CIA $23.69
- SLP N/A
- Revenue Growth
- CIA N/A
- SLP 20.01
- 52 Week Low
- CIA $2.90
- SLP $12.39
- 52 Week High
- CIA $5.95
- SLP $37.67
- Technical
- Relative Strength Index (RSI)
- CIA 60.56
- SLP 43.15
- Support Level
- CIA $5.04
- SLP $13.93
- Resistance Level
- CIA $5.46
- SLP $14.52
- Average True Range (ATR)
- CIA 0.21
- SLP 0.50
- MACD
- CIA -0.05
- SLP 0.10
- Stochastic Oscillator
- CIA 59.17
- SLP 11.86
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.